7 followers
RT @jrkelly: Debate over details of US biosimilar pathway continues to rage http://t.co/IGmQiqgT
RT @jrkelly: Debate over details of US biosimilar pathway continues to rage http://t.co/IGmQiqgT
RT @bermaninstitute: Debate over details of US biosimilar pathway continues to rage http://t.co/0d3aVNUN #Bioethics
Debate over details of US biosimilar pathway continues to rage http://t.co/IGmQiqgT
RT @bermaninstitute: Debate over details of US biosimilar pathway continues to rage http://t.co/0d3aVNUN #Bioethics